FORTREN FUNDING

fortren-funding-logo

Fortren Funding was created with one focus; to be a new kind of mortgage company for a post great recession America. Their highly experienced management team witnessed first-hand what went wrong during Americaโ€™s financial crisis.

#People #Website #More

FORTREN FUNDING

Social Links:

Industry:
Financial Services Real Estate Real Estate Investment

Founded:
2011-01-01

Address:
Livingston, New Jersey, United States

Country:
United States

Website Url:
http://www.fortren.com

Total Employee:
101+

Status:
Closed

Contact:
(855)693-3832

Email Addresses:
[email protected]

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps GoDaddy DNS Google Maps API Facebook Sharer CloudFront Pinterest


Current Employees Featured

not_available_image

Mark Gordon
Mark Gordon Founder & CEO @ Fortren Funding
Founder & CEO

Founder


not_available_image

Mark Gordon

Official Site Inspections

http://www.fortren.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Fortren Funding"

Our Leadership | Fortrea

Tom joined the organization as President and Chief Executive Officer in January 2023 during Fortreaโ€™s spinoff from its parent company, Labcorp (NYSE: LH). Tom has more than 30 years โ€ฆSee details»

Fortrea - Wikipedia

Fortrea Holdings Inc. is a contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I thrโ€ฆSee details»

Overview | Fortrea

Fortrea (Nasdaq: FTRE) is a leading global contract research organization (CRO) helping customers bring life-changing solutions to patients faster. With over 19,000 professionals โ€ฆSee details»

Careers - Fortrea

Fortrea is a company dedicated to the idea that people at all levels of our organization should reflect the communities we serve. Diversity, equity, inclusion and belonging are more than just โ€ฆSee details»

Fortrea - LinkedIn

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical ...See details»

Fortrea Launches as Leading, Global Contract Research โ€ฆ

Jul 3, 2023 Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster Fortrea Holdings Inc Updated Mon, Jul 3, โ€ฆSee details»

Life-Changing Therapies to Patients Faster - Fortrea

Jul 3, 2023 Fortrea Media: Sue Zaranek 919.943.5422, [email protected] Fortrea Media: Kate Dillon 646-818-9115, [email protected] Fortrea Investors: Hima Inguva 1-877-495-0816, โ€ฆSee details»

Labcorp Unveils New Name for Future Independent Clinical โ€ฆ

Feb 9, 2023 Fortrea Will Become a Leading, Pure-play CRO Focused on Driving Innovation and Improving Patient Outcomes Worldwide Spin-off Remains on Track to Be Completed in Mid โ€ฆSee details»

Fortrea - Crunchbase Company Profile & Funding

Fortrea provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and โ€ฆSee details»

Fortrea Holdings Inc. (FTRE) - Yahoo Finance Canada

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company โ€ฆSee details»

Fortrea to Present at the Evercore HealthCONx Conference

Nov 26, 2024 Fortrea Holdings Inc. DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today โ€ฆSee details»

Fortrea Introduces Comprehensive Solution to Improve Diversity โ€ฆ

DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the โ€œCompanyโ€), a leading global contract research organization (CRO), today announced its โ€ฆSee details»

News Releases - Fortrea

Aug 12, 2024 DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and โ€ฆSee details»

The Fortrea Culture

When Fortrea evolved from our heritage as Covance and Labcorp, we seized the opportunity to build a unique culture. With engagement from employees across Fortrea and by collecting โ€ฆSee details»

Fortrea to Present at the Evercore HealthCONx Conference

DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief โ€ฆSee details»

Fortrea - Overview, News & Similar companies | ZoomInfo.com

Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the โ€ฆSee details»

Critical Insights From Fortrea Holdings Analyst Ratings: What

1 day ago Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and โ€ฆSee details»

Fortrea Releases Inaugural Corporate Social Responsibility Report

Oct 17, 2024 more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter). Fortrea Contacts: Hima โ€ฆSee details»

Fortrea shares soared Wednesday after reportedly canceling from ...

2 days ago Fortrea (NASDAQ:FTRE) soared 10% on Wednesday at least partly after the contract research organization reportedly cancelled from some sell-side conferences. Fortrea โ€ฆSee details»

Fortrea Holdings Inc. (NASDAQ:FTRE) Position Lessened by โ€ฆ

10 hours ago Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. โ€ฆSee details»